Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Early evaluation critical for kidney disease patients’ survival

17.09.2002


"We need to get (chronic kidney disease) on the radar screen, especially when there’s a medical history of high blood pressure or diabetes, so both patients and physicians are more aware of the consequences and opportunities to intervene." - Neil R. Powe, M.D., M.P.H.



Kidney disease patients are at a much increased risk of death when they have delays getting to a specialist, a Johns Hopkins-led study shows. Delays occur more often among black males, the uninsured and those who have multiple illnesses.

Results of the study, published in the Sept. 17 issue of the Annals of Internal Medicine, show that a third of chronic kidney disease patients were evaluated by a nephrologist only four months before having to start life-saving dialysis treatment. Those evaluated late were more likely to die within two years after starting dialysis. Delayed evaluation typically is associated with a higher risk of unplanned first dialysis and complications as well as increased hospital costs and length of stay.


While the study did not examine reasons for the delay in getting specialty care, senior author Neil R. Powe, M.D., M.P.H., M.B.A., says these probably include poor access to primary care, delayed or absent referral to a specialist from a primary care doctor and patients’ lack of information about the importance of early intervention.

"There also are many people who have chronic kidney disease and may not know it, so they may not be under a physician’s care," says Powe, director of Hopkins’ Welch Center for Prevention, Epidemiology and Clinical Research. "We need to get the condition on the radar screen, especially when there’s a medical history of high blood pressure or diabetes, so both patients and physicians are more aware of the consequences and opportunities to intervene. These patients should be under the care of a doctor and should talk to their doctors about seeing a nephrologist before their disease progresses to the point at which they need dialysis."

Powe and colleagues examined data from the Choices for Healthy Outcomes in Caring for End-stage renal disease (CHOICE) Study, a Hopkins effort that followed more than 1,000 dialysis patients nationwide between October 1995 and June 1998. For this study, they reviewed information on 828 patients just starting dialysis, asking them to complete a questionnaire on their medical and social history and provide the month and year in which they first visited a nephrologist.

They also compared the time between each patient’s first visit to a nephrologist and the start of his or her dialysis program. They defined early evaluation as first seeing a nephrologist more than a year before the start of dialysis and late evaluation as first seeing a nephrologist less than four months before dialysis. Patient survival rates were tracked for two years.

Thirty percent of patients were seen by a nephrologist less than four months prior to starting dialysis, compared to 22 percent evaluated between four and 12 months before dialysis, and 48 percent evaluated more than a year before dialysis. Late evaluation was more common among black men than white men (45 percent versus 25 percent), uninsured patients than insured patients (57 percent versus 29 percent) and patients with severe co-existing disease than those with mild or no co-existing disease (35 percent versus 23 percent). Those evaluated late were less likely to have received erythropoeitin, a hormone necessary to boost red blood cell production.

During an average follow-up period of 2.2 years, 201 of the patients died. Among those who were evaluated late, death rates were 13 percent one year after starting dialysis and 28 percent two years after starting dialysis. By comparison, among those evaluated early, the death rates were 4 percent and 15 percent, respectively.

Approximately 8 million people in the United States have moderate kidney disease, and another 300,000 have end-stage renal disease (ESRD), Powe says. Annual U.S. spending related to treatment of ESRD exceeds $15 billion. The patient population studied was 55 percent male, 28 percent black and 65 percent younger than age 65.

Karen Blum | EurekAlert!

More articles from Health and Medicine:

nachricht A promising target for kidney fibrosis
21.04.2017 | Brigham and Women's Hospital

nachricht Stem cell transplants: activating signal paths may protect from graft-versus-host disease
20.04.2017 | Technische Universität München

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

7th International Conference on Crystalline Silicon Photovoltaics in Freiburg on April 3-5, 2017

03.04.2017 | Event News

 
Latest News

NASA's Fermi catches gamma-ray flashes from tropical storms

25.04.2017 | Physics and Astronomy

Researchers invent process to make sustainable rubber, plastics

25.04.2017 | Materials Sciences

Transfecting cells gently – the LZH presents a GNOME prototype at the Labvolution 2017

25.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>